TPC
Takeda Pharmaceutical Company Portfolio holdings
AUM $19.6M
1-Year Return
13.61%
This Quarter Return
+25.17%
1 Year Return
-13.61%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$19.6M
AUM Growth
+$3.36M
(+21%)
Cap. Flow
-$9
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
99.9%
Holding
11
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Lyell Immunopharma
LYEL
|
+$9 |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
HilleVax
HLVX
$105M
| $13.4M | 68.43% |
6,724,000
| – | – |
|
2
Ovid Therapeutics
OVID
$82.5M
| $2.49M | 12.71% |
7,531,996
| – | – |
|
3
Xilio Therapeutics
XLO
$39.1M
| $1M | 5.13% |
1,475,121
| – | – |
|
4
American Well
AMWL
$105M
| $691K | 3.53% |
77,733
| – | – |
|
5
Equillium
EQ
$91M
| $575K | 2.94% |
1,824,977
| – | – |
|
6
Shattuck Labs
STTK
$92.9M
| $408K | 2.09% |
515,619
| – | – |
|
|
7
Lyell Immunopharma
LYEL
$236M
| $364K | 1.86% |
41,165
-1
| -0% | -$9 |
|
|
TSBX
8
DELISTED
Turnstone Biologics
TSBX
| $322K | 1.64% |
895,824
| – | – |
|
|
THRD
9
DELISTED
Third Harmonic Bio
THRD
| $200K | 1.02% |
36,835
| – | – |
|
10
Rani Therapeutics
RANI
$22.5M
| $104K | 0.53% |
203,190
| – | – |
|
11
Standard BioTools
LAB
$516M
| $19.8K | 0.1% |
16,515
| – | – |
|